Current situation and prospect of interventional therapy for congenital heart disease in China
- VernacularTitle:中国先天性心脏病介入治疗现状与展望
- Author:
Yiming YAN
1
,
2
,
3
,
4
,
5
;
Wenbin OUYANG
1
,
2
,
3
,
4
,
5
;
Fengwen ZHANG
1
,
2
,
3
,
4
,
5
;
Fang FANG
1
,
2
,
3
,
4
,
5
;
Xiangbin PAN
1
,
2
,
3
,
4
,
5
Author Information
1. 1.Department of Structural Heart Disease, National Center for Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Sciences &
2. Peking Union Medical College, Beijing, 100037, P. R. China
3. 2. National Health Commission Key Laboratory of Cardiovascular Regeneration Medicine, Beijing, 100037, P. R. China
4. 3. Key Laboratory of Innovative Cardiovascular Devices, Chinese Academy of Medical Sciences, Beijing, 100037, P. R. China
5. 4. National Clinical Research Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing, 100037, P. R. China
- Publication Type:Journal Article
- Keywords:
Congenital heart disease;
interventional therapy;
occluder device;
commentary
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2022;29(10):1243-1253
- CountryChina
- Language:Chinese
-
Abstract:
Transcatheter intervention for congenital heart disease has been developed for 40 years in China, it has experienced the transition of learning to self-dependent innovation, and witnessed the intervention therapy system starting from scratch and gradually reaching the top level and gaining high achievements in the world scale. With the continuous development of interventional technology and devices, cutting-edge ideas and viewpoints are constantly discussed. This review summarized the development of intervention techniques and devices, hoping to provide some experience for the further development of transcatheter interventions for congenial heart disease.
